The purpose of this study is to assess the long term safety and efficacy of the vaginal application of Gynoflor®, an extremely low dosed estrogen therapy with lactobacilli, on atrophic vaginitis in postmenopausal breast cancer patients who have been treated with aromatase inhibitors.
Age range
52 Years – 75 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Serum Concentrations of Estriol (E3)
Timeframe: -0.5, 0.5, 1, 2, 3, 4, 6, 8, 24 hours on days 0 and 28
Calculation of Pharmacokinetic Parameters Estriol: Cmax
Timeframe: Days 0 and 28
Calculation of Pharmacokinetic Parameters Estriol: Tmax
Timeframe: Days 0 and 28
Calculation of Pharmacokinetic Parameters Estriol: Area Under the Curve (AUC)
Timeframe: Days 0 and 28